SATT Pulsalys

SATT Pulsalys
Name	SATT Pulsalys
Founded	2012
Headquarters	Lyon, France
Region served	Auvergne-Rhône-Alpes
Type	Technology transfer office

SATT Pulsalys

SATT Pulsalys is a French technology transfer company active in the Auvergne-Rhône-Alpes region, created to bridge public research and industry through intellectual property valorization, startup creation, and licensing. It operates in close relation with universities, grandes écoles, research institutes, and hospitals in Lyon and Grenoble, aiming to accelerate commercialization of innovations across sectors such as biotechnology, information technology, materials science, and energy. SATT Pulsalys engages with a network of regional, national, and European actors to support translational research, entrepreneurship, and industrial collaboration.

History

SATT Pulsalys was established in 2012 as part of the French Investissements d’Avenir initiative alongside other SATTs like SATT Grand Est, SATT Lutech, and SATT Ouest Valorisation to professionalize technology transfer following frameworks set by the French Ministry of Higher Education and Research and the Agence nationale de la recherche. Its formation consolidated technology transfer activities from institutions including Université Claude Bernard Lyon 1, Université Lumière Lyon 2, Université Jean Moulin Lyon 3, École Normale Supérieure de Lyon, INSA Lyon, CentraleSupélec partners and research organizations such as CNRS, INSERM, and CEA. Over time Pulsalys expanded collaborations with regional bodies like the Région Auvergne-Rhône-Alpes and metropolitan authorities including Métropole de Lyon and institutions in the Grenoble ecosystem such as Grenoble INP and Université Grenoble Alpes. The company followed precedents from international technology transfer models exemplified by MIT Technology Licensing Office, Stanford Office of Technology Licensing, and Cambridge Enterprise while adapting to French legal regimes such as the Code de la propriété intellectuelle.

Mission and Activities

Pulsalys’s mission emphasizes accelerating the transfer of publicly funded research to market through invention disclosure evaluation, patent prosecution, proof-of-concept funding, and startup incubation, working alongside actors like Bpifrance, European Investment Bank, and EIT Health. Activities include scouting technologies across disciplines represented by partners such as Lyonbiopôle, Tenerrdis, and Minalogic; managing intellectual property portfolios in coordination with legal firms and patent departments associated with INPI standards; and supporting spin-offs by connecting founders to incubators like Incubateur HEC, Creative Valley, and accelerators like Station F. Pulsalys provides services ranging from technology maturation funding similar to Horizon 2020 mechanisms to licensing negotiations influenced by practices from Oxford University Innovation and Imperial Innovations.

Structure and Governance

Pulsalys is governed by a board composed of representatives from founding institutions including Université Claude Bernard Lyon 1, Université Jean Moulin Lyon 3, École Normale Supérieure de Lyon, regional authorities such as Région Auvergne-Rhône-Alpes, and industrial partners including members from Schneider Electric, Sanofi, and BioMérieux. Executive management aligns with corporate governance norms comparable to Société par actions simplifiée frameworks and reports to shareholders drawn from universities, research organizations like CNRS and INSERM, and public investors such as Caisse des Dépôts. Operational units coordinate with technology clusters like Axelera and Cluster Lumière and interface with clinical partners such as Hospices Civils de Lyon for translational projects. Advisory committees include academics from institutions like ENS Lyon and industry experts with backgrounds at companies like Bayer and GE Healthcare.

Funding and Partnerships

Funding sources for Pulsalys include capital injections from institutional shareholders, project-based grants from Investissements d’Avenir, competitive research programs such as ANR, and co-investment with venture funds like Seventure Partners and Serena Capital. Partnerships encompass regional clusters including Lyonbiopôle, public research organizations CNRS and CEA, technology incubators such as Incubateur Impulse, and corporate partners including Air Liquide and EDF for collaborative development and licensing deals. Pulsalys also participates in European consortiums funded under programs like Horizon Europe and collaborates with innovation agencies including Bpifrance Création and international transfer offices such as Karolinska Innovations and TTOs at ETH Zurich.

Technology Transfer and Portfolio

The Pulsalys portfolio spans patents, startup equity, and licensing agreements across fields represented by partners like Inserm Transfert, Lyon Neuroscience Research Center, CIRAD collaborations, and laboratories affiliated with CNRS UMRs. Technologies marketed include biomedical devices, diagnostics, software tools, materials, and energy solutions, drawing on expertise found at Hospices Civils de Lyon, Institut Pasteur, and engineering schools like Polytech Grenoble. Pulsalys applies valuation and IP strategies informed by international precedents such as AUTM guidelines and engages external patent attorneys and venture partners seen in transactions involving Lazard-advised deals or corporate venture arms like Novartis Venture Fund. The office supports proof-of-concept studies, regulatory pathways involving ANSM, and market validation with corporate partners like Zimmer Biomet.

Impact and Notable Projects

Pulsalys has contributed to the creation of spin-offs and licenses that reached markets through collaborations with companies like bioMérieux, Sanofi, and Thales. Notable projects include support for medtech startups emerging from collaborations with Hospices Civils de Lyon and translational programs tied to Lyonbiopôle initiatives, as well as materials and energy projects aligned with CEA and EDF research. The organization’s portfolio links to innovations showcased at events like VivaTech, CES, and regional innovation summits organized by French Tech Lyon. Outcomes include job creation, follow-on investment from funds such as Partech and Idinvest Partners, and contributions to regional competitiveness strategies led by Métropole de Lyon and Région Auvergne-Rhône-Alpes.

Controversies and Criticism

Critiques of technology transfer entities like Pulsalys reference debates seen in cases involving Bayh–Dole Act-style policies, tensions over academic authorship rights exemplified in disputes at institutions like University of California and concerns about public return on investment debated in reports by Cour des comptes. Allegations can include prioritization of proprietary IP over open science, conflicts between academic openness at CNRS-affiliated labs and commercialization imperatives, and management of equity stakes reminiscent of scrutiny faced by other European SATT entities. Pulsalys has engaged in dialogues with stakeholders including university governance boards, regional policymakers such as Conseil régional d'Auvergne-Rhône-Alpes, and national actors like Ministère de l'Enseignement supérieur et de la Recherche to address transparency, conflict-of-interest policies, and performance metrics.

Category:Technology transfer organizations